Herbal Medicine Containing Aristolochic Acid and the Risk of Primary Liver Cancer in Patients with Hepatitis C Virus Infection
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Journal Volume
28
Journal Issue
11
Pages
1876
Date Issued
2019
Author(s)
Chen, Chi-Jen
Pau-Chung CHEN
Lin, Meng-Hung
Lee, Chuan-Pin
Pau-Chung CHENChen, Pau-Chung
Doyle, Pat
Ho, Wen-Chao
Abstract
We investigated the association between taking herbal medicine (HM) containing aristolochic acid (AA) and the risk of primary liver cancer (PLC) among patients with hepatitis C virus (HCV) infection.
SDGs
Other Subjects
acetylsalicylic acid; aristolochic acid; atorvastatin; benazepril; captopril; cilazapril; enalapril; fluindostatin; fosinopril; interferon; lisinopril; metformin; mevinolin; perindopril; pravastatin; quinapril; ramipril; ribavirin; rosuvastatin; simvastatin; aristolochic acid; aristolochic acid I; carcinogen; adult; aged; Article; cancer risk; Chinese medicine; clinical evaluation; cohort analysis; disease association; female; follow up; hepatitis C; herbal medicine; human; incidence; liver cancer; major clinical study; male; middle aged; national health insurance; population research; prescription; priority journal; prospective study; chemistry; complication; Hepacivirus; hepatitis C; herbal medicine; liver tumor; pathogenicity; procedures; risk factor; Aristolochic Acids; Carcinogens; Female; Hepacivirus; Hepatitis C; Herbal Medicine; Humans; Liver Neoplasms; Male; Prospective Studies; Risk Factors
Publisher
AMER ASSOC CANCER RESEARCH
Type
journal article